#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Enteritis Myelodysplastic syndrome with excess blasts Erdheim-Chester disease General anaesthesia Vernal keratoconjunctivitis Congenital pseudarthrosis Pancreatic carcinoma Sexually transmitted disease Osteosarcoma recurrent Progressive supranuclear palsy Hypergammaglobulinaemia benign monoclonal Hypocalcaemia Infection in an immunocompromised host Adrenogenital syndrome Exudative retinopathy More trials…

    Learn about Rare Diseases

    Brain stem glioma Pituitary-dependent Cushing’s syndrome – Trials in Disease Small intestine leiomyosarcoma Haemophilia A with anti factor VIII – Diagnostics Atypical haemolytic uraemic syndrome Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease MELAS syndrome – Basic Information Brain stem glioma – Basic Information Waldenstrom’s macroglobulinaemia refractory – Life with Disease Osteosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ELTANEXOR TORASEMIDE Paracetamol Dc [18F]Alf-Nota-Octreotide ACICLOVIR SODIUM Dc-806 Luspatercept AZD0516 BI-1607 Chlorpromazine Hydrochloride ABBV-CLS-628 Infigratinib BUDOPRUTUG Jab-21822 Flecainide Levetiracetam GSKVX000000048111 Azd2693 Sodium Mcla-129 Letrozole More therapies…

    Learn about Your Condition

    Acute lymphocytic leukaemia Immunodeficiency Cytomegalovirus infection Hypereosinophilic syndrome Choroid melanoma Bone marrow failure Large cell lung cancer stage 0 Acquired haemophilia Impaired gastric emptying Pathogen resistance Acute kidney injury Staphylococcal bacteraemia Cardiac ventricular thrombosis Schizophreniform disorder Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

    Recruiting

    4 1
    Investigated Drugs:
    • Inaxaplin
    Belgium France

  • Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

    Recruiting

    2 1
    Investigated Drugs:
    • Ambroxol Hydrochloride
    Norway

  • Study on the Effects of Dexamethasone and Oseltamivir in Patients with Severe Influenza

    Recruiting

    3 1 1
    Investigated Diseases:
    • H1N1 influenza
    Investigated Drugs:
    • Oseltamivir
    • Cellulose, Microcrystalline
    • Betamethasone Sodium Phosphate
    Spain

  • Study on Hydroxychloroquine for Patients with Cutaneous Mastocytosis or Indolent Systemic Mastocytosis with Skin Involvement

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mastocytosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    France

  • Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Capecitabine
    • Pembrolizumab
    • Sacituzumab Govitecan
    Belgium France Germany Ireland Italy Spain

  • Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Neoplasm malignant
    Investigated Drugs:
    • Petosemtamab
    • Calcium Folinate
    • Fluorouracil
    Belgium France Italy The Netherlands Spain
Previous Page
1 … 621 622 623 624 625 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!